However, contrary to these findings, there is also evidence that IL-10 together with IL-35 — the latter a CD4+ and CD8+ T cell-suppressing and T regulatory cell (Treg)-supporting cytokine upregulated in AML (118) — promotes AML cell proliferation, survival and chemoresistance. This evidence concerns the gene IL10 and acute myeloid leukemia.